P2.03-056 Primary Double EGFR Mutations T790M and Mutation in Exon 19 or 21 in Slovakiab NSCLC Patients - Updated Survival Data von Berzinec, P., Kasan, P., Godal, R., Plank, L., Copakova, L., Alemayehu, A., Chowaniecova, G., Farkasova, A., Hlavcak, P., Kucma, M., Rotikova, L., Slavikova, M., Vasovcak, P.

Volltext

Evaluation of 2-Year Experience With EGFR Mutation Analysis of Small Diagnostic Samples von Hlinkova, Katarina, Babal, Pavel, Berzinec, Peter, Majer, Ivan, Mikle-Barathova, Zdenka, Piackova, Barbora, Ilencikova, Denisa

Volltext

Resource Use of Non-Small Cell Lung Cancer in Slovakia von Ondrusova, M, Psenkova, M, Berzinec, P, Basso, F

Volltext

DNA repair genes polymorphism and lung cancer risk with the emphasis to sex differences von Letkova, L., Matakova, T., Musak, L., Sarlinova, M., Krutakova, M., Slovakova, P., Kavcova, E., Jakusova, V., Janickova, M., Drgova, A., Berzinec, P., Halasova, E.

Volltext

EP1.04-19 First Experience with Atezolizumab in Slovakia von Kasan, P., Berzinec, P., Cerna, M., Andrasina, I., Cipkova, A., Chowaniecova, G., Denkova, L., Godal, R., Kuzmova, H., Svihelova – Liskova, Z., Martak, M., Mazal, J., Obertova, J., Pribulova, Z., Urda, M., Vesela, M.

Volltext

EGFR mutations in squamous NSCLC – Prevalence and treatment results with EGFR tyrosine kinase inhibitors (TKIs) in patients from western Slovakia von Berzinec, P, Hlinkova, K, Copakova, L, Konecny, M, Zavodna, K, Cerna, M, Culagova, M, Chowaniecova, G, Babal, P

Volltext

EP1.14-34 Advanced NSCLC Treated with Gefitinib or Erlotinib for Five Years or Longer - Updated Data from the Retrospective Slovakian Study von Berzinec, P., Kasan, P., Mazal, J., Andrasina, I., Cipkova, A., Chowaniecova, G., Martak, M., Urda, M., Vesela, M., Jancokova, I., Kuliskova, I., Plank, L.

Volltext

P3.13-11 Advanced NSCLC Treated with Gefitinib or Erlotinib for Five Years or Longer - Retrospective Slovakian Study von Berzinec, P., Kasan, P., Mazal, J., Andrasina, I., Cipkova, A., Chowaniecova, G., Martak, M., Urda, M., Vesela, M., Plank, L.

Volltext

Gene polymorphisms of biotransforming enzymes (GSTs) and their association with lung cancer in the Slovakian population von Matakova, T, Sivonova, M, Halasova, E, Mistuna, D, Dzian, A, Berzinec, P, Letkova, L, Dobrota, D

Volltext

PCN148 - Resource Use of Non-Small Cell Lung Cancer in Slovakia von Ondrusova, M., Psenkova, M., Berzinec, P., Basso, F.

Volltext

6510 ORAL Erlotinib in patients with advanced non-small-cell lung cancer (NSCLC): interim results from the European subpopulation of the open-label TRUST study von Smit, E, Reck, M, Krzakowski, M, Gridelli, C, Curescu, S, Berzinec, P, Barata, F, McDermott, R, Jovanovic, D, Magyar, P

Volltext

Advanced NSCLC Treated with Gefitinib or Erlotinib for Five Years or Longer - Updated Data from the Retrospective Slovakian Study: EP1.14-34 von Berzinec, P, Kasan, P, Mazal, J, Andrasina, I, Cipkova, A, Chowaniecova, G, Martak, M, Urda, M, Vesela, M, Jancokova, I, Kuliskova, I, Plank, L

Volltext

20 Synchronous and metachronous lung cancer other than adenocarcinoma in women with breast cancer von Berzinec, P., Detvay, J.

Volltext

Initial safety results of an expanded access program (EAP) of erlotinib in non-small cell lung cancer (NSCLC) von Reck, M., Perng, R., Groen, H., Riska, H., Pirker, R., Sederholm, C., Caspar, C., Boyer, M., Berzinec, P., Allan, S.

Volltext

Stop lung cancer — community aimed project von Berzinec, P, Dlhy, J

Volltext

Carcinoembryonic antigen (CEA) levels in pleural effusion and serum in differentiation of malignant and benign pleural effusion: Berzinec P, Plutinsky J, Zrubcova K, Vondrak V, Letkovicova M. Puskinova 134, 94901 Nitra. Radiol Oncol 1994;28:316–319

Volltext

Cytostatic chemotherapy for small cell lung cancer in patients of age 75 years or older: Berzinec P, Kroslak M, Petricek S, Arpasova M, Kuzmova H. Department of Oncology, Inst. of TB and Respiratory Diseases, Puskinova 134, 949.88 Nitra. Radiol Oncol 1995; 29: 236–239

Volltext

Reactivation tuberculosis in lung cancer patients treated with cytostatic chemotherapy von Berzinec, P, Petricek, S, Kuzmova, H

Volltext

First Experience with Atezolizumab in Slovakia: EP1.04-19 von Kasan, P, Berzinec, P, Cerna, M, Andrasina, I, Cipkova, A, Chowaniecova, G, Denkova, L, Godal, R, Kuzmova, H, Svihelova – Liskova, Svihelova Z, Martak, M, Mazal, J, Obertova, J, Pribulova, Z, Urda, M, Vesela, M

Volltext

839 Serum tumour marker CYFRA 21-1 as a prognostic factor in squamous cell lung cancer — Comparison with CEA von Berzinec, P., Zuffova, H.

Volltext